<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C6D7EBF-E8D6-4375-A4DF-B67ECC019601"><gtr:id>9C6D7EBF-E8D6-4375-A4DF-B67ECC019601</gtr:id><gtr:name>Department of Life Sciences (encompassing Biology)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F6AC48F8-C411-48D1-B60A-ABCE724A4BB8"><gtr:id>F6AC48F8-C411-48D1-B60A-ABCE724A4BB8</gtr:id><gtr:name>International Mouse Phenotyping Consortium (IMPC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EE303FB4-A2B0-46C2-B888-442F65D89A02"><gtr:id>EE303FB4-A2B0-46C2-B888-442F65D89A02</gtr:id><gtr:name>Leibniz Institute for Analytical Sciences (ISAS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Human Genetics</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C6D7EBF-E8D6-4375-A4DF-B67ECC019601"><gtr:id>9C6D7EBF-E8D6-4375-A4DF-B67ECC019601</gtr:id><gtr:name>Department of Life Sciences (encompassing Biology)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F6AC48F8-C411-48D1-B60A-ABCE724A4BB8"><gtr:id>F6AC48F8-C411-48D1-B60A-ABCE724A4BB8</gtr:id><gtr:name>International Mouse Phenotyping Consortium (IMPC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EE303FB4-A2B0-46C2-B888-442F65D89A02"><gtr:id>EE303FB4-A2B0-46C2-B888-442F65D89A02</gtr:id><gtr:name>Leibniz Institute for Analytical Sciences (ISAS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/06E9C900-A07E-4D04-A0C3-0DF79EA9BB4E"><gtr:id>06E9C900-A07E-4D04-A0C3-0DF79EA9BB4E</gtr:id><gtr:firstName>HKM</gtr:firstName><gtr:surname>Lochmuller</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1002274"><gtr:id>9D5974E4-B227-4C5F-ADD8-4CC60AB8A91D</gtr:id><gtr:title>Novel pathogenic mechanisms implicated in defects of neuromuscular transmission</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002274</gtr:grantReference><gtr:abstractText>Congenital myasthenic syndromes (CMS) are a group of inherited diseases that cause muscle weakness in children and adults. CMS affect the neuromuscular junction (NMJ), a link structure that is responsible for transmitting signals from nerves to muscles, causing muscles to contract. When this link breaks down, or functions less efficiently, the patient gets tired very quickly and can be severely disabled. The condition may be life-threatening, when breathing muscles are affected. We have recently discovered mutations in a new gene called GFAT1 which cause a previously unrecognised form of CMS. At the moment it is not yet understood how mutations in GFAT1 interfere with NMJ function and structure to cause CMS. We have found out that the amount of GFAT1 protein present in the muscle tissue of patients is considerably diminished compared to healthy control muscle. Our aim is therefore to study the consequences of the loss of GFAT1 for muscle function and for communication between nerve and muscle. 
Many proteins carry sugar residues on their surface which are important for their function. The GFAT1 enzyme produces a metabolite that is essential for all reactions that add sugar residues onto proteins. We plan to investigate whether proteins lose their sugar modification in GFAT1 patients, which proteins are affected most by this and what the implications are for the correct function of a muscle cell.
As sugar modification of proteins is a very general mechanism in all cell types, our results may not only improve our knowledge of CMS, but also contribute to the understanding of sugar modifications on proteins of the nerve cells in diseases such as Alzheimer?s disease and in muscle for the development of type 2 diabetes.</gtr:abstractText><gtr:technicalSummary>Congenital myasthenic syndromes (CMS) are inherited neuromuscular transmission defects characterised by fluctuating muscle weakness and fatigability, leading to loss of mobility and respiratory failure. A distinct form of CMS, pyridostigmine-responsive limb-girdle CMS, has not previously been associated with any gene defect. Recently, we linked this condition to a locus on chromosome 2p12-15 by genome-wide mapping and identified mutations in the GFAT1 gene as the underlying genetic defect. Subsequently we established that GFAT1 mutations lead to a loss of GFAT1 expression in patient muscle. In contrast to all other CMS genes, GFAT1 is expressed in most tissues. 
This is the first association of CMS with a non-structural, ubiquitous protein, suggesting novel pathogenic mechanisms leading to NMJ dysfunction. The proposed project aims at understanding how GFAT1 mutations cause an impairment of neuromuscular transmission.
The GFAT1 enzyme regulates the flux through the hexosamine biosynthetic pathway which yields the precursor substrates for protein and lipid glycosylation. This includes N- and O- glycosylation of transmembrane and secreted proteins as well as the posttranslational modification by one O-linked beta-N-Acetylglucosamine residue of nucleocytoplasmic proteins (O-GlcNAcylation). In this project we will investigate the consequence of GFAT1 deficiency on these two types of glycosylation for skeletal muscle and NMJ proteins. We will study glycosylation in GFAT1 deficient C2C12 muscle cells, in GFAT1 deficient zebrafish as an animal model and in patient material. Several NMJ transmembrane proteins such as the acetylcholine receptor and the muscle-specific kinase MuSK are glycosylated. We will determine whether GFAT1 deficiency results in a modification of glycosyl residues on these proteins and whether this affects acetylcholine receptor clustering at the NMJ and the NMJ structure in zebrafish. Moreover, O-GlcNAcylation of nuclear and cytoplasmic proteins has been linked to stress response in cells and is thought to have a cytoprotective function. Inability of GFAT1 deficient cells to regulate their stress response might leave them more prone to stress-related damage. We will identify which proteins are O-GlcNAcylated in C2C12 cells, which of these are most affected by GFAT1 deficiency, and how this relates to stress tolerance.
Our findings will improve our understanding of posttranslational modifications of the neuromuscular junction. We will determine to what degree disturbed protein glycosylation constitutes a new basic pathogenic mechanism resulting in a synaptic defect.</gtr:technicalSummary><gtr:fund><gtr:end>2015-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>568522</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>David Beeson Collaboration</gtr:description><gtr:id>15927D9D-73CB-44D3-A889-F9ACA1D9F0AA</gtr:id><gtr:impact>Previous joint publications (eg. Beeson et al., 2006)

Upcoming joint publication on novel glycosylation gene mutations in CMS</gtr:impact><gtr:partnerContribution>Sequencing data</gtr:partnerContribution><gtr:piContribution>Identification and provision of patient material for analysis, identification of novel mutations in specific glycosylation genes,</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Mouse Phenotyping Consortium (IMPC)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Neuromouse Consortium</gtr:description><gtr:id>07D9152A-0829-4606-9FEB-A13F45759EA0</gtr:id><gtr:impact>Mouse strains are being prepared for dispatch from Harwell.</gtr:impact><gtr:partnerContribution>The wider consortium is providing mouse knock-outs and phenotyping data, notably on the Gfpt1 conditional mouse knock-out</gtr:partnerContribution><gtr:piContribution>We have been involved in the prioritisation of genes for targeting as part of a wider consortium.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Basel (Universit?t Basel)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Biozentrum Basel</gtr:department><gtr:description>Markus Ruegg Collaboration</gtr:description><gtr:id>BA42D69C-9275-4CCB-A40E-F7CE0ECD9907</gtr:id><gtr:impact>Still under development</gtr:impact><gtr:partnerContribution>Electroporation of mouse muscle</gtr:partnerContribution><gtr:piContribution>Development of Gfpt1 shRNA resources for transient knowckdown in mouse muscle</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Life Sciences (encompassing Biology)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biopolymer Mass Spectrometry Group</gtr:department><gtr:description>Anne Dell Collaboration</gtr:description><gtr:id>0239B023-99F8-4ED1-8A84-9E24A7C4F7BD</gtr:id><gtr:impact>Results are being analysed</gtr:impact><gtr:partnerContribution>Investigation of the effect of GFPT1 deficiency on the glycome of cell cultures</gtr:partnerContribution><gtr:piContribution>Generation of cell material for mass spectrometric glycomic analysis with and without GFPT1</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Mouse Phenotyping Consortium (IMPC)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Neuromouse Consortium</gtr:description><gtr:id>529D4DFE-B748-45DE-AC55-89DDB91B1EE8</gtr:id><gtr:impact>Mouse strains are being prepared for dispatch from Harwell.</gtr:impact><gtr:partnerContribution>The wider consortium is providing mouse knock-outs and phenotyping data, notably on the Gfpt1 conditional mouse knock-out</gtr:partnerContribution><gtr:piContribution>We have been involved in the prioritisation of genes for targeting as part of a wider consortium.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Mary Lyon Centre</gtr:department><gtr:description>Neuromouse Consortium</gtr:description><gtr:id>768B73CF-48EC-4A7D-8527-C6A7B86FDB87</gtr:id><gtr:impact>Mouse strains are being prepared for dispatch from Harwell.</gtr:impact><gtr:partnerContribution>The wider consortium is providing mouse knock-outs and phenotyping data, notably on the Gfpt1 conditional mouse knock-out</gtr:partnerContribution><gtr:piContribution>We have been involved in the prioritisation of genes for targeting as part of a wider consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leibniz Institute for Analytical Sciences (ISAS)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Albert Sickmann Collaboration</gtr:description><gtr:id>B3E16E55-CBFA-442F-A6F3-CFDF92D2CEBD</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:partnerContribution>Proteomic studies</gtr:partnerContribution><gtr:piContribution>Proteomic studies to unravel the molecular basis of neuromuscular diseases</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EDECF79A-A66F-4B46-AD3D-75328789508C"><gtr:id>EDECF79A-A66F-4B46-AD3D-75328789508C</gtr:id><gtr:title>The risk of re-identification versus the need to identify individuals in rare disease research.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a83ca1e41ba01ec1a43c1cb1cda8ae9"><gtr:id>4a83ca1e41ba01ec1a43c1cb1cda8ae9</gtr:id><gtr:otherNames>Hansson MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E3F5965-68F4-49D9-9959-733A0A346D80"><gtr:id>3E3F5965-68F4-49D9-9959-733A0A346D80</gtr:id><gtr:title>Clinical features of the myasthenic syndrome arising from mutations in GMPPB.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa0b6ef76225dc642b86c7e03e3cfd59"><gtr:id>aa0b6ef76225dc642b86c7e03e3cfd59</gtr:id><gtr:otherNames>Rodr?guez Cruz PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FEDB1769-BC79-4C89-99C6-DFFA8888127E"><gtr:id>FEDB1769-BC79-4C89-99C6-DFFA8888127E</gtr:id><gtr:title>Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40a020e11c4ea5657e5f2e6f3485cfd0"><gtr:id>40a020e11c4ea5657e5f2e6f3485cfd0</gtr:id><gtr:otherNames>Bansagi B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D36BD3CB-E386-475F-B71E-4BABC66D6492"><gtr:id>D36BD3CB-E386-475F-B71E-4BABC66D6492</gtr:id><gtr:title>Phenotypic variability of TRPV4 related neuropathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fe8fc4c7a21a2eb5369f6c0eb70d891a"><gtr:id>fe8fc4c7a21a2eb5369f6c0eb70d891a</gtr:id><gtr:otherNames>Evangelista T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9027FC4-A49D-4E9F-B8D5-B546DF48BCC8"><gtr:id>F9027FC4-A49D-4E9F-B8D5-B546DF48BCC8</gtr:id><gtr:title>Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18692bc909f1f653c05eed67803ff70d"><gtr:id>18692bc909f1f653c05eed67803ff70d</gtr:id><gtr:otherNames>Lorenzoni PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B0B6260-FCFD-4CB6-B2CC-2ED4082D1F51"><gtr:id>5B0B6260-FCFD-4CB6-B2CC-2ED4082D1F51</gtr:id><gtr:title>Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e87940e6460d8a108148a5e207bd528"><gtr:id>0e87940e6460d8a108148a5e207bd528</gtr:id><gtr:otherNames>Whittaker RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3DD1FB42-04E0-401F-B829-E533FC31B8C6"><gtr:id>3DD1FB42-04E0-401F-B829-E533FC31B8C6</gtr:id><gtr:title>The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fe8fc4c7a21a2eb5369f6c0eb70d891a"><gtr:id>fe8fc4c7a21a2eb5369f6c0eb70d891a</gtr:id><gtr:otherNames>Evangelista T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A6AD424-1ABA-4DFB-9C7D-280ABE2BA435"><gtr:id>4A6AD424-1ABA-4DFB-9C7D-280ABE2BA435</gtr:id><gtr:title>DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c498c08db8013d31d27379b0a356001"><gtr:id>9c498c08db8013d31d27379b0a356001</gtr:id><gtr:otherNames>Mahjneh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F8F7E96-261D-4E8B-95BF-00DF9D76B435"><gtr:id>9F8F7E96-261D-4E8B-95BF-00DF9D76B435</gtr:id><gtr:title>Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fe8fc4c7a21a2eb5369f6c0eb70d891a"><gtr:id>fe8fc4c7a21a2eb5369f6c0eb70d891a</gtr:id><gtr:otherNames>Evangelista T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0187272C-2001-4D06-BBDA-E836460CE1E4"><gtr:id>0187272C-2001-4D06-BBDA-E836460CE1E4</gtr:id><gtr:title>Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/365ff300e2e52c02bd4f9ddb9d00cffe"><gtr:id>365ff300e2e52c02bd4f9ddb9d00cffe</gtr:id><gtr:otherNames>Gallenm?ller C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9BC2660-0AC0-447A-9880-063ED2FF756D"><gtr:id>E9BC2660-0AC0-447A-9880-063ED2FF756D</gtr:id><gtr:title>Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1).</gtr:title><gtr:parentPublicationTitle>Biomolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87baae63149e8384883159bbff301f14"><gtr:id>87baae63149e8384883159bbff301f14</gtr:id><gtr:otherNames>Chen Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2218-273X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CC8D91F5-B935-4CE3-8FDF-049A9B8B6660"><gtr:id>CC8D91F5-B935-4CE3-8FDF-049A9B8B6660</gtr:id><gtr:title>A 3'-UTR mutation creates a microRNA target site in the GFPT1 gene of patients with congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53b52465e547418fd22d0bcb2bef6912"><gtr:id>53b52465e547418fd22d0bcb2bef6912</gtr:id><gtr:otherNames>Dusl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5797A4FE-2954-4FBB-9C77-B1B56DF06435"><gtr:id>5797A4FE-2954-4FBB-9C77-B1B56DF06435</gtr:id><gtr:title>Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/51cba051719f81ef2c20624dca20d9fa"><gtr:id>51cba051719f81ef2c20624dca20d9fa</gtr:id><gtr:otherNames>Cossins J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2388A856-8E7A-4D8F-8C86-A0281C338169"><gtr:id>2388A856-8E7A-4D8F-8C86-A0281C338169</gtr:id><gtr:title>Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa72e1487b5c9616d7251983f1a41ed9"><gtr:id>aa72e1487b5c9616d7251983f1a41ed9</gtr:id><gtr:otherNames>Natera-de Benito D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C9AE1F6E-7CF1-432D-909B-731B5E2AB719"><gtr:id>C9AE1F6E-7CF1-432D-909B-731B5E2AB719</gtr:id><gtr:title>Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8fa6da02e6d2cc8f4bf898c81e9d324"><gtr:id>f8fa6da02e6d2cc8f4bf898c81e9d324</gtr:id><gtr:otherNames>Bauch? S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/605F1E60-30A3-484C-8241-D1F62D9BD2FB"><gtr:id>605F1E60-30A3-484C-8241-D1F62D9BD2FB</gtr:id><gtr:title>Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5626171956afc05c22fb6e090f4588fb"><gtr:id>5626171956afc05c22fb6e090f4588fb</gtr:id><gtr:otherNames>O'Connor E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB782913-C4DD-4638-8AC2-203D19E2BD1E"><gtr:id>BB782913-C4DD-4638-8AC2-203D19E2BD1E</gtr:id><gtr:title>A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9ffcbe5f6fef07cf1358edb003fbe6d5"><gtr:id>9ffcbe5f6fef07cf1358edb003fbe6d5</gtr:id><gtr:otherNames>Vissing J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/62897289-D6D3-41C8-89DA-8A40538C5D96"><gtr:id>62897289-D6D3-41C8-89DA-8A40538C5D96</gtr:id><gtr:title>Quantifying the burden of caregiving in Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f870d8e6a42d39d68ef51eb9a6cfd8c9"><gtr:id>f870d8e6a42d39d68ef51eb9a6cfd8c9</gtr:id><gtr:otherNames>Landfeldt E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F2AFA9B-B43B-4D6D-A6A8-A38EFEE8F2F1"><gtr:id>9F2AFA9B-B43B-4D6D-A6A8-A38EFEE8F2F1</gtr:id><gtr:title>Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f870d8e6a42d39d68ef51eb9a6cfd8c9"><gtr:id>f870d8e6a42d39d68ef51eb9a6cfd8c9</gtr:id><gtr:otherNames>Landfeldt E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2285F2C-0BF2-499E-B4B3-AEF984742BBA"><gtr:id>E2285F2C-0BF2-499E-B4B3-AEF984742BBA</gtr:id><gtr:title>Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f46ce8597d265963cae03471c26f8e21"><gtr:id>f46ce8597d265963cae03471c26f8e21</gtr:id><gtr:otherNames>Zoltowska K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8FA8FD3-BD99-42D7-ACC4-3351C433FE51"><gtr:id>B8FA8FD3-BD99-42D7-ACC4-3351C433FE51</gtr:id><gtr:title>A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92cf2dd7e98f0d1ff4c60ca219551d89"><gtr:id>92cf2dd7e98f0d1ff4c60ca219551d89</gtr:id><gtr:otherNames>Chaouch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4CBDBD3E-9C3C-4E08-88D9-323130DCBA34"><gtr:id>4CBDBD3E-9C3C-4E08-88D9-323130DCBA34</gtr:id><gtr:title>Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3b09cec3df0253fb5c98e8674910a85a"><gtr:id>3b09cec3df0253fb5c98e8674910a85a</gtr:id><gtr:otherNames>Herrmann DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BD6C372-F7A8-4F9F-BC19-398424DDB1CF"><gtr:id>3BD6C372-F7A8-4F9F-BC19-398424DDB1CF</gtr:id><gtr:title>Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT).</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f870d8e6a42d39d68ef51eb9a6cfd8c9"><gtr:id>f870d8e6a42d39d68ef51eb9a6cfd8c9</gtr:id><gtr:otherNames>Landfeldt E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86500FDB-AAED-4B3D-AA55-E3F2699B826A"><gtr:id>86500FDB-AAED-4B3D-AA55-E3F2699B826A</gtr:id><gtr:title>Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48214cd8e3234e8568330fdf7a825156"><gtr:id>48214cd8e3234e8568330fdf7a825156</gtr:id><gtr:otherNames>Nicole S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61404DF8-4B24-46FF-AF8D-37CB3E58852A"><gtr:id>61404DF8-4B24-46FF-AF8D-37CB3E58852A</gtr:id><gtr:title>Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18692bc909f1f653c05eed67803ff70d"><gtr:id>18692bc909f1f653c05eed67803ff70d</gtr:id><gtr:otherNames>Lorenzoni PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96A0E1C7-B6E3-45A2-A2A2-23E43ED41109"><gtr:id>96A0E1C7-B6E3-45A2-A2A2-23E43ED41109</gtr:id><gtr:title>Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/434e40ded37f7645cc9042937bf60439"><gtr:id>434e40ded37f7645cc9042937bf60439</gtr:id><gtr:otherNames>Abicht A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6636DD44-0CA4-4E7A-903F-1C15E7A4B4B2"><gtr:id>6636DD44-0CA4-4E7A-903F-1C15E7A4B4B2</gtr:id><gtr:title>EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5d75d3b4b9bf032eb6ff10990933d59"><gtr:id>e5d75d3b4b9bf032eb6ff10990933d59</gtr:id><gtr:otherNames>Boczonadi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93627E10-1971-4591-8D05-4534B26B94B2"><gtr:id>93627E10-1971-4591-8D05-4534B26B94B2</gtr:id><gtr:title>Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef1daab582c85c7641d8fd3dea00cc9e"><gtr:id>ef1daab582c85c7641d8fd3dea00cc9e</gtr:id><gtr:otherNames>Belaya K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/608CF42D-B2BA-4BB5-9D00-617525BBA01D"><gtr:id>608CF42D-B2BA-4BB5-9D00-617525BBA01D</gtr:id><gtr:title>The Human Phenotype Ontology in 2017.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/78a6df497981c50c665eb3d5386c7edf"><gtr:id>78a6df497981c50c665eb3d5386c7edf</gtr:id><gtr:otherNames>K?hler S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F46C68B-0F06-4799-B66C-B087958F00D8"><gtr:id>3F46C68B-0F06-4799-B66C-B087958F00D8</gtr:id><gtr:title>Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d06b561712784c15d64b1b782c8bb4fe"><gtr:id>d06b561712784c15d64b1b782c8bb4fe</gtr:id><gtr:otherNames>Khan MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87844BC4-3F95-4227-8083-F41883F4D3FF"><gtr:id>87844BC4-3F95-4227-8083-F41883F4D3FF</gtr:id><gtr:title>Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the a-e subunit interface.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8f022b8687d82dc8df9d836a488d074d"><gtr:id>8f022b8687d82dc8df9d836a488d074d</gtr:id><gtr:otherNames>Webster R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13D3FC85-9EC4-4CBC-980D-F6C659B1880F"><gtr:id>13D3FC85-9EC4-4CBC-980D-F6C659B1880F</gtr:id><gtr:title>Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9424d7e37ca3a2d7f9ecbaa8e24e2c06"><gtr:id>9424d7e37ca3a2d7f9ecbaa8e24e2c06</gtr:id><gtr:otherNames>Guergueltcheva V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5DE6AE18-C597-462C-B78C-B91D35DAAFF4"><gtr:id>5DE6AE18-C597-462C-B78C-B91D35DAAFF4</gtr:id><gtr:title>'You should at least ask'. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4ddf96f03c4b1d183c1afa7fac13f33"><gtr:id>b4ddf96f03c4b1d183c1afa7fac13f33</gtr:id><gtr:otherNames>McCormack P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002274</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>